PYR Fundamental Analysis - PYRUM INNOVATIONS AG

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to PYR. PYR was compared to 42 industry peers in the Commercial Services & Supplies industry. PYR has a bad profitability rating. Also its financial health evaluation is rather negative. PYR is valued quite expensively, but it does show have an excellent growth rating.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year PYR has reported negative net income.

PYR had a negative operating cash flow in the past year.

In the past 5 years PYR always reported negative net income.

In the past 5 years PYR always reported negative operating cash flow.

1.2 Ratios

PYR's Return On Assets of -16.30% is on the low side compared to the rest of the industry. PYR is outperformed by 80.95% of its industry peers.

PYR has a worse Return On Equity (-55.22%) than 78.57% of its industry peers.

		Industry Rank	Sector Rank
ROA	-16.3%
ROE	-55.22%
ROIC	N/A

ROA(3y)-16.56%

ROA(5y)-17.52%

ROE(3y)-37.72%

ROE(5y)-37.23%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

PYR's Gross Margin of 159.78% is amongst the best of the industry. PYR outperforms 100.00% of its industry peers.

In the last couple of years the Gross Margin of PYR has grown nicely.

The Profit Margin and Operating Margin are not available for PYR so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	159.78%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y16.22%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

PYR does not have a ROIC to compare to the WACC, probably because it is not profitable.

PYR has more shares outstanding than it did 1 year ago.

PYR has a worse debt/assets ratio than last year.

2.2 Solvency

PYR has an Altman-Z score of 1.59. This is a bad value and indicates that PYR is not financially healthy and even has some risk of bankruptcy.

With a Altman-Z score value of 1.59, PYR perfoms like the industry average, outperforming 45.24% of the companies in the same industry.

A Debt/Equity ratio of 1.61 is on the high side and indicates that PYR has dependencies on debt financing.

PYR's Debt to Equity ratio of 1.61 is on the low side compared to the rest of the industry. PYR is outperformed by 64.29% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	1.61
Debt/FCF	N/A
Altman-Z	1.59

ROIC/WACCN/A

WACC6.55%

2.3 Liquidity

A Current Ratio of 0.68 indicates that PYR may have some problems paying its short term obligations.

PYR has a worse Current ratio (0.68) than 80.95% of its industry peers.

A Quick Ratio of 0.51 indicates that PYR may have some problems paying its short term obligations.

PYR has a Quick ratio of 0.51. This is amonst the worse of the industry: PYR underperforms 83.33% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.68
Quick Ratio	0.51

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

PYR shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.53%.

The Revenue has grown by 90.75% in the past year. This is a very strong growth!

The Revenue has been growing by 29.91% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)6.53%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-56.92%

Revenue 1Y (TTM)90.75%

Revenue growth 3Y29.92%

Revenue growth 5YN/A

Sales Q2Q%103.79%

3.2 Future

Based on estimates for the next years, PYR will show a very strong growth in Earnings Per Share. The EPS will grow by 23.67% on average per year.

The Revenue is expected to grow by 104.03% on average over the next years. This is a very strong growth

EPS Next Y3.65%

EPS Next 2Y14.16%

EPS Next 3Y19.01%

EPS Next 5Y23.67%

Revenue Next Year141.68%

Revenue Next 2Y237.64%

Revenue Next 3Y186.45%

Revenue Next 5Y104.03%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PYR. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PYR. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as PYR's earnings are expected to grow with 19.01% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y14.16%

EPS Next 3Y19.01%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

PYR does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

PYRUM INNOVATIONS AG

FRA:PYR (1/5/2026, 7:00:00 PM)

27.2

-0.7 (-2.51%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCommercial & Professional Services

GICS IndustryCommercial Services & Supplies

Earnings (Last)11-22 2024-11-22

Earnings (Next)N/A N/A

Inst Owners0.82%

Inst Owner ChangeN/A

Ins Owners14.72%

Ins Owner ChangeN/A

Market Cap124.58M

Revenue(TTM)2.58M

Net Income(TTM)-9.94M

Analysts82.86

Price Target57.46 (111.25%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0.6%

PT rev (3m)26.46%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)1.38%

EPS NY rev (3m)0.4%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)-3.33%

Revenue NY rev (3m)-3.33%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	48.26
P/FCF	N/A
P/OCF	N/A
P/B	6.92
P/tB	9.28
EV/EBITDA	N/A

EPS(TTM)-2.84

EYN/A

EPS(NY)-2.02

Fwd EYN/A

FCF(TTM)-3

FCFYN/A

OCF(TTM)-1.04

OCFYN/A

SpS0.56

BVpS3.93

TBVpS2.93

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-16.3%
ROE	-55.22%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	159.78%
FCFM	N/A

ROA(3y)-16.56%

ROA(5y)-17.52%

ROE(3y)-37.72%

ROE(5y)-37.23%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y16.22%

GM growth 5YN/A

F-Score5

Asset Turnover0.04

Health

		Industry Rank	Sector Rank
Debt/Equity	1.61
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	257.31%
Cap/Sales	347.91%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.68
Quick Ratio	0.51
Altman-Z	1.59

F-Score5

WACC6.55%

ROIC/WACCN/A

Cap/Depr(3y)569.11%

Cap/Depr(5y)414.55%

Cap/Sales(3y)1213.37%

Cap/Sales(5y)858.81%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)6.53%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-56.92%

EPS Next Y3.65%

EPS Next 2Y14.16%

EPS Next 3Y19.01%

EPS Next 5Y23.67%

Revenue 1Y (TTM)90.75%

Revenue growth 3Y29.92%

Revenue growth 5YN/A

Sales Q2Q%103.79%

Revenue Next Year141.68%

Revenue Next 2Y237.64%

Revenue Next 3Y186.45%

Revenue Next 5Y104.03%

EBIT growth 1Y8.65%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year43.01%

EBIT Next 3Y37.1%

EBIT Next 5Y46.25%

FCF growth 1Y38.91%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y21.39%

OCF growth 3YN/A

OCF growth 5YN/A

PYRUM INNOVATIONS AG / PYR.DE FAQ

What is the fundamental rating for PYR stock?

ChartMill assigns a fundamental rating of 2 / 10 to PYR.DE.

Can you provide the valuation status for PYRUM INNOVATIONS AG?

ChartMill assigns a valuation rating of 0 / 10 to PYRUM INNOVATIONS AG (PYR.DE). This can be considered as Overvalued.

What is the profitability of PYR stock?

PYRUM INNOVATIONS AG (PYR.DE) has a profitability rating of 1 / 10.

What is the financial health of PYRUM INNOVATIONS AG (PYR.DE) stock?

The financial health rating of PYRUM INNOVATIONS AG (PYR.DE) is 0 / 10.

PYRUM INNOVATIONS AG (PYR.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

PYRUM INNOVATIONS AG / PYR.DE FAQ

What is the fundamental rating for PYR stock?

Can you provide the valuation status for PYRUM INNOVATIONS AG?

What is the profitability of PYR stock?

What is the financial health of PYRUM INNOVATIONS AG (PYR.DE) stock?